The aim of this study was to evaluate the effect of switching to a quick-acting insulin analogue (Q) from regular insulin (R) in 40 children and adolescents with type 1 diabetes. The major insulin regimens before the administration of Q were as follows: R-R-R-N (U), 28 patients (70%); and RN-R-R-N, 1 patient 2.5%, Twelve months after the use of Q, the insulin regimens were increased to twice daily injections of basal insulin: Q-Q-Q-N (U), 18 patients (45%); and QN, -Q (R)-Q (R)-N, 9 patients (12.5%). Eight patients (20%) received the modified use of a bolus of Q or R insulin depending on their life-style. The mean dose of total insulin remained unchanged during treatment with Q, but the mean basal insulin dose increased 12 months after the use of Q (baseline 25.8±12.2 U/day, after 12 months 27.1±12.6 U/day).After switching to Q, the mean HbA
1c value decreased in all patients (baseline 7.6±1.0 U/day, after 12 months 7.3±0.8%), reflecting an improvement in HbA
1c in patients with an HbA
1c value≥8% at baseline.These results indicate that the effects of the insulin regimens varied after switching from R to Q, with increases in the numbers and dosages of the basal insulin injection.The use of Q seemed to improve glycemic control in patients with a poor glucose profile under conventional insulin treatment using R.
View full abstract